Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In a series of 12 patients (eight women and four men, aged between 20 and 62 years), operated on for a pituitary adenoma shown to be thyrotropic by immunocytochemistry, we performed a retrospective and comparative analysis of clinical and biological data, tumor studies including immunocytochemistry with double labeling, and proliferation marker (proliferative cell nuclear antigen (PCNA) and Ki-67) detection, electron microscopy and culture. Our study leads us to confirm that thyrotropic tumors are rare (12 of 1174 pituitary adenomas: 1%). The main points arising were that: (1) high or normal plasma TSH associated with an increase in plasma alpha-subunit and high thyroid hormone levels is the best criterion for diagnosis; (2) the failure of TSH to respond to TRH or Werner's test is not a reliable criterion for diagnosis; (3) thyrotropic adenomas may be 'silent', without clinical signs of hyperthyroidism and with only slight increase in TSH, tri-iodothyronine and thyroxine concentrations; (4) mitoses and nuclear atypies are frequently detected in large tumors, which are invasive in more than 50% of cases - the first analysis of two proliferation markers (PCNA and Ki-67) bears out the relative aggressiveness of thyrotropic adenomas; (5) thyrotropic adenomas are frequently plurihormonal. Immunocytochemical double labeling, complemented by in vitro study, showed that thyrotropic tumor cells sometimes can or sometimes cannot cosecrete TSH, GH or prolactin. The pathological identification of monohormonal and plurihormonal adenomas seems to be supported by clinical and biological differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variable biological activity of thyroid-stimulating hormone
Beck-Peccoz, P., & Persani, L. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310331 · Cited by 116 · cited 1×
“Thus the bioactivity/immunoreactivity ratio of the released TSH may be normal, reduced ( 17 , 18) or even increased (19), while the intratumor TSH resembles that in a normal pituitary (16).”
BackgroundGrossmann, M., Szkudlinski, M. W., Tropea, J. E., Bishop, L. A., Thotakura, N. R., Schofield, P. R., & Weintraub, B. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29378 · Cited by 61
Cited by
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
Socin, H., Chanson, P., Delemer, B., Tabarin, A., Rohmer, V, Mockel, J., Stevenaert, A., & Beckers, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480433 · Cited by 274
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
Önnestam, L., Berinder, K., Burman, P., Dahlqvist, P., Engström, B. E., Wahlberg, J., & Nyström, H. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3362 · Cited by 148
A 2019 update on TSH-secreting pituitary adenomas
Beck-Peccoz, P., Giavoli, C., & Lania, A. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01066-x · Cited by 111
Metadata
- Authors
- Bertholon-Gregoire, M., Trouillas, J., Guigard, M., Loras, B., & Tourniaire, J.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06-01
- Volume
- 140
- Issue
- 6
- Pages
- 519-527
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2130858725
- Cited by
- 60
- References
- 2
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. https://app.cochat.ai/papers/10.1530/eje.0.1400519
- The paper
- Bertholon-Gregoire, M., Trouillas, J., Guigard, M., Loras, B., & Tourniaire, J. (1999). Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1400519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.